|
US20040067532A1
(en)
|
2002-08-12 |
2004-04-08 |
Genetastix Corporation |
High throughput generation and affinity maturation of humanized antibody
|
|
EP1982176A1
(en)
*
|
2006-01-30 |
2008-10-22 |
Dako Denmark A/S |
High-speed quantification of antigen specific t-cells in whole blood by flow cytometry
|
|
EP1878744A1
(en)
|
2006-07-13 |
2008-01-16 |
Max-Delbrück-Centrum für Molekulare Medizin (MDC) |
Epitope-tag for surface-expressed T-cell receptor proteins, uses thereof and method of selecting host cells expressing them
|
|
EP2518193A3
(en)
*
|
2006-11-15 |
2013-01-23 |
Invitrogen Dynal AS |
Methods for reversibly binding a biotin compound to a support
|
|
WO2008116468A2
(en)
|
2007-03-26 |
2008-10-02 |
Dako Denmark A/S |
Mhc peptide complexes and uses thereof in infectious diseases
|
|
WO2009003493A2
(en)
|
2007-07-03 |
2009-01-08 |
Dako Denmark A/S |
Mhc multimers, methods for their generation, labeling and use
|
|
US8877688B2
(en)
|
2007-09-14 |
2014-11-04 |
Adimab, Llc |
Rationally designed, synthetic antibody libraries and uses therefor
|
|
US12529164B2
(en)
|
2007-09-14 |
2026-01-20 |
Adimab, Llc |
Rationally designed, synthetic antibody libraries and uses therefor
|
|
JP5933894B2
(ja)
|
2007-09-14 |
2016-06-15 |
アディマブ， エルエルシー |
合理的に設計された、合成抗体ライブラリおよびその使用
|
|
EP2197908A2
(en)
|
2007-09-27 |
2010-06-23 |
Dako Denmark A/S |
Mhc multimers in tuberculosis diagnostics, vaccine and therapeutics
|
|
DK2254592T3
(da)
|
2008-02-28 |
2019-09-09 |
Dako Denmark As |
MHC-multimerer til Borrelia-diagnostik og sygdom
|
|
US10722562B2
(en)
|
2008-07-23 |
2020-07-28 |
Immudex Aps |
Combinatorial analysis and repair
|
|
GB0817244D0
(en)
|
2008-09-20 |
2008-10-29 |
Univ Cardiff |
Use of a protein kinase inhibitor to detect immune cells, such as T cells
|
|
US11992518B2
(en)
|
2008-10-02 |
2024-05-28 |
Agilent Technologies, Inc. |
Molecular vaccines for infectious disease
|
|
US10369204B2
(en)
|
2008-10-02 |
2019-08-06 |
Dako Denmark A/S |
Molecular vaccines for infectious disease
|
|
WO2011034115A1
(ja)
*
|
2009-09-17 |
2011-03-24 |
Jsr株式会社 |
アビジンとビオチン誘導体の解離方法及び解離剤
|
|
AU2011249041B2
(en)
|
2010-05-06 |
2014-10-30 |
Adaptive Biotechnologies Corp. |
Monitoring health and disease status using clonotype profiles
|
|
PT2619223T
(pt)
*
|
2010-09-21 |
2019-07-11 |
Us Health |
Recetores de células t anti-ssx-2 e materiais e métodos de utilização relacionados
|
|
WO2012044999A2
(en)
*
|
2010-10-01 |
2012-04-05 |
Ludwig Institute For Cancer Research Ltd. |
Reversible protein multimers, methods for their production and use
|
|
PT2734538T
(pt)
*
|
2011-07-18 |
2018-08-02 |
Iba Gmbh |
Processo para corar, de forma reversível, uma célula-alvo
|
|
WO2013056090A1
(en)
*
|
2011-10-12 |
2013-04-18 |
University Of Connecticut |
Affinity-based materials for the non-destructive separation and recovery of cells
|
|
WO2013124474A2
(en)
|
2012-02-23 |
2013-08-29 |
Stage Cell Therapeutics Gmbh |
Chromatographic isolation of cells and other complex biological materials
|
|
CN102662054B
(zh)
*
|
2012-05-10 |
2014-08-13 |
东南大学 |
一种同步检测特异性胸腺依赖性淋巴细胞数量和功能的方法
|
|
EP2920204B1
(en)
|
2012-11-16 |
2019-09-18 |
IBA GmbH |
Streptavidin muteins and methods of using them
|
|
SG11201605046YA
(en)
*
|
2013-12-20 |
2016-07-28 |
Hutchinson Fred Cancer Res |
Tagged chimeric effector molecules and receptors thereof
|
|
CA2936914C
(en)
|
2014-01-21 |
2020-08-18 |
Stemcell Technologies Inc. |
Method for separating target entities from a sample using a composition of mono-specific tetrameric antibody complexes coupled to a surface
|
|
EP3132247B1
(en)
|
2014-04-16 |
2021-08-18 |
Juno Therapeutics GmbH |
Methods, kits and apparatus for expanding a population of cells
|
|
ES2995052T3
(en)
|
2014-04-23 |
2025-02-05 |
Juno Therapeutics Inc |
Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy
|
|
CA2945414C
(en)
|
2014-04-30 |
2023-05-09 |
Iba Gmbh |
Method of isolating a target cell
|
|
EP3037820A1
(en)
|
2014-12-27 |
2016-06-29 |
Miltenyi Biotec GmbH |
Cell detection methods and reagents having a releasable labelling moiety
|
|
WO2016166568A1
(en)
|
2015-04-16 |
2016-10-20 |
Juno Therapeutics Gmbh |
Methods, kits and apparatus for expanding a population of cells
|
|
WO2016176652A2
(en)
|
2015-04-29 |
2016-11-03 |
Fred Hutchinson Cancer Research Center |
Modified stem cells and uses thereof
|
|
JP6657721B2
(ja)
|
2015-09-30 |
2020-03-04 |
ソニー株式会社 |
細胞の分析方法、細胞分析用チップ、細胞分析用試薬、細胞分析用キット及び細胞分析用装置
|
|
EP3365678A1
(en)
|
2015-10-22 |
2018-08-29 |
Juno Therapeutics GmbH |
Methods for culturing cells and kits and apparatus for same
|
|
EP3365453A2
(en)
|
2015-10-22 |
2018-08-29 |
Juno Therapeutics GmbH |
Methods, kits, agents and apparatuses for transduction
|
|
IL258844B2
(en)
|
2015-10-22 |
2024-03-01 |
Juno Therapeutics Gmbh |
Methods for culturing cells and kits and apparatus for same
|
|
WO2017180420A1
(en)
|
2016-04-11 |
2017-10-19 |
Board Of Regents, The University Of Texas System |
Methods and compositions for detecting single t cell receptor affinity and sequence
|
|
JP7165060B2
(ja)
*
|
2016-06-28 |
2022-11-02 |
テクニッシェ ウニヴェルズィテート ミュンヘン |
受容体－リガンドｋｏｆｆ速度を分析するための可逆的細胞標識および不可逆的細胞標識の組み合わせ
|
|
WO2018029350A2
(en)
|
2016-08-11 |
2018-02-15 |
Kite Pharma Eu B.V. |
Methods of making and using soluble mhc molecules
|
|
US10294454B2
(en)
|
2016-08-24 |
2019-05-21 |
General Electric Company |
Methods and kits for cell activation
|
|
EP3336545A1
(en)
|
2016-12-13 |
2018-06-20 |
Miltenyi Biotec GmbH |
Reversible labeling of antigens in biological specimens
|
|
EP3336546B1
(en)
|
2016-12-13 |
2020-07-01 |
Miltenyi Biotec B.V. & Co. KG |
Reversible cell labelling with conjugates having two releasable binding sites
|
|
CA3050085A1
(en)
|
2017-01-20 |
2018-07-26 |
Juno Therapeutics Gmbh |
Cell surface conjugates and related cell compositions and methods
|
|
EP4647493A3
(en)
|
2017-04-27 |
2026-01-14 |
Juno Therapeutics, Inc. |
Oligomeric particle reagents and methods of use thereof
|
|
ES3009018T3
(en)
|
2017-07-29 |
2025-03-25 |
Juno Therapeutics Inc |
Reagents for expanding cells expressing recombinant receptors
|
|
EP3489684B1
(en)
|
2017-11-27 |
2024-06-26 |
Miltenyi Biotec B.V. & Co. KG |
Method for photobleaching stained cells
|
|
WO2019113557A1
(en)
|
2017-12-08 |
2019-06-13 |
Juno Therapeutics, Inc. |
Process for producing a composition of engineered t cells
|
|
CN116148467A
(zh)
*
|
2017-12-12 |
2023-05-23 |
清华大学 |
检测翻译后修饰蛋白质与其配体间相互作用的成套试剂
|
|
CA3108657A1
(en)
|
2018-08-09 |
2020-02-13 |
Juno Therapeutics, Inc. |
Processes for generating engineered cells and compositions thereof
|
|
WO2020048876A1
(en)
|
2018-09-03 |
2020-03-12 |
Technische Universitaet Muenchen |
A double peptide tag combining reversibility and flexible functionalization
|
|
JP7504891B2
(ja)
|
2018-09-11 |
2024-06-24 |
ジュノー セラピューティクス インコーポレイテッド |
操作された細胞組成物のマススペクトロメトリー分析のための方法
|
|
US12522660B2
(en)
|
2018-10-31 |
2026-01-13 |
C3S2 Gmbh |
Methods for selection and stimulation of cells and apparatus for same
|
|
CA3117720A1
(en)
|
2018-11-06 |
2020-05-14 |
Juno Therapeutics, Inc. |
Process for producing genetically engineered t cells
|
|
EP3898666A2
(en)
|
2018-12-17 |
2021-10-27 |
Immudex ApS |
Panel comprising borrelia mhc multimers
|
|
MX2021012285A
(es)
|
2019-04-09 |
2021-12-15 |
Nurix Therapeutics Inc |
Compuestos de piperidina 3-sustituidos para inhibicion del protooncogen-b de linfoma de linea b de casitas (cbl-b) y uso de un inhibidor de cbl-b en combinacion con una vacuna contra el cancer y/o con un virus oncolitico.
|
|
EP3953489A1
(en)
|
2019-04-12 |
2022-02-16 |
Miltenyi Biotec B.V. & Co. KG |
Conjugates having an enzymatically releasable detection moiety and a barcode moiety
|
|
AU2020278592B2
(en)
|
2019-05-17 |
2024-10-10 |
Nurix Therapeutics, Inc. |
Cyano cyclobutyl compounds for Cbl-b inhibition and uses thereof
|
|
US20220220504A1
(en)
|
2019-05-28 |
2022-07-14 |
Miltenyi Biotec B.V. & Co. KG |
Method for Generation of Genetically Modified T Cells
|
|
CA3139965A1
(en)
|
2019-06-07 |
2020-12-10 |
Ivie AIFUWA |
Automated t cell culture
|
|
MX2021015675A
(es)
|
2019-06-26 |
2022-02-03 |
Nurix Therapeutics Inc |
Compuestos de bencil-triazol sustituidos para la inhibicion de cbl-b y otros usos de los mismos.
|
|
CA3148769A1
(en)
|
2019-07-30 |
2021-02-04 |
Nurix Therapeutics, Inc. |
Urea, amide, and substituted heteroaryl compounds for cbl-b inhibition
|
|
US12444491B2
(en)
|
2019-08-30 |
2025-10-14 |
Juno Therapeutics, Inc. |
Machine learning methods for classifying cells
|
|
US20220315894A1
(en)
|
2019-09-11 |
2022-10-06 |
Miltenyi Biotec B.V. & Co. KG |
Method for Transduction of T Cells in the Presence of Malignant Cells
|
|
IL292319B2
(en)
|
2019-10-30 |
2026-01-01 |
C3S2 Gmbh |
Cell selection and/or stimulation devices and methods of use
|
|
WO2021122185A1
(en)
|
2019-12-20 |
2021-06-24 |
Miltenyi Biotec B.V. & Co. KG |
Reversible cell detection via mhc with conjugates having an enzymatically cleavable detection moiety
|
|
US20230090117A1
(en)
|
2020-01-28 |
2023-03-23 |
Juno Therapeutics, Inc. |
Methods for t cell transduction
|
|
US11965882B2
(en)
|
2020-01-31 |
2024-04-23 |
Cell.Copedia GmbH |
Methods of isolating a biological entity
|
|
MX2022009830A
(es)
|
2020-02-12 |
2022-10-28 |
Juno Therapeutics Inc |
Composiciones de celulas t que expresan receptores de antigenos quimericos dirigidos a bcma y metodos y usos de las mismas.
|
|
IL295384A
(en)
|
2020-02-12 |
2022-10-01 |
Juno Therapeutics Inc |
Cd19-directed chimeric antigen receptor t cell compositions and methods and uses thereof
|
|
JP2023526278A
(ja)
|
2020-05-13 |
2023-06-21 |
ジュノー セラピューティクス インコーポレイテッド |
組み換え受容体を発現しているドナーバッチ細胞を産生するための方法
|
|
EP3916393B1
(en)
|
2020-05-27 |
2023-01-25 |
Miltenyi Biotec B.V. & Co. KG |
Method for detection of cells by repetitive staining and destaining
|
|
EP4204809A1
(en)
|
2020-08-27 |
2023-07-05 |
Miltenyi Biotec B.V. & Co. KG |
Releasable reagents for cell separation
|
|
JP7612841B2
(ja)
|
2020-09-07 |
2025-01-14 |
ミルテニー バイオテック ベー．フェー． ウント コー． カー・ゲー |
酵素的に放出可能な検出部分およびバーコード部分を有するコンジュゲート
|
|
KR20240018454A
(ko)
|
2021-05-06 |
2024-02-13 |
주노 테라퓨틱스 게엠베하 |
T 세포의 자극 및 형질도입 방법
|
|
WO2023017115A1
(en)
|
2021-08-11 |
2023-02-16 |
Iba Lifesciences Gmbh |
Fractionation of cells based on a marker protein
|
|
EP4227423A1
(en)
|
2022-02-09 |
2023-08-16 |
Technische Universität München |
Means and methods for identifying high affinity t-cells
|
|
US20250297282A1
(en)
|
2022-05-05 |
2025-09-25 |
Juno Therapeutics Gmbh |
Viral-binding protein and related reagents, articles, and methods of use
|
|
WO2023230581A1
(en)
|
2022-05-25 |
2023-11-30 |
Celgene Corporation |
Methods of manufacturing t cell therapies
|
|
EP4615960A1
(en)
|
2022-11-09 |
2025-09-17 |
C3S2 GmbH |
Methods for manufacturing engineered immune cells
|
|
JP2026501122A
(ja)
|
2022-12-09 |
2026-01-14 |
ジュノー セラピューティクス インコーポレイテッド |
ホログラフィックイメージングを使用して細胞表現型を予測するための機械学習方法
|
|
CN121002052A
(zh)
|
2023-02-03 |
2025-11-21 |
C3S2 有限公司 |
用于非病毒生产工程化免疫细胞的方法
|
|
CN121127253A
(zh)
|
2023-02-28 |
2025-12-12 |
朱诺治疗学股份有限公司 |
治疗系统性自身免疫性疾病的细胞疗法
|
|
EP4484441A1
(en)
|
2023-06-26 |
2025-01-01 |
Eberhard-Karls-Universität Tübingen |
Mhc-class i derived polypeptide
|
|
WO2025083196A1
(en)
|
2023-10-18 |
2025-04-24 |
Tq Therapeutics Gmbh |
A method of manufacturing a cellular therapy product and respective kits and devices
|